Access Programs Arcutis's Zoryve Direct Program demonstrates a scalable patient and payer support model that can drive adoption; leverage this framework to secure formulary access, optimize copay assistance, and accelerate uptake of current and future dermatology therapies.

Portfolio Growth As a commercial-stage company led by an experienced dermatology team with an immuno-dermatology focus, there are opportunities for co-promotion, licensing, or strategic partnerships to broaden the product portfolio and speed market penetration.

Payer Advantage Revenue momentum combined with active access programs positions Arcutis to negotiate favorable payor contracts, formulary placements, and patient assistance terms to increase reachable patient segments.

Leadership Edge Recent leadership appointments and board changes suggest stronger governance and transaction capability, enhancing deal evaluation, risk management, and execution in partnerships and collaborations.

Digital Engagement The existing tech stack supports scalable talent management and marketing operations; convert this into effective physician outreach and direct-to-physician campaigns to accelerate adoption across dermatology networks and optimize cross-sell of Zoryve and future products.